Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Largest borrow rate increases among liquid names » 08:45
03/24/23
03/24
08:45
03/24/23
08:45
KBAL

Kimball International

$12.23 /

+0.04 (+0.33%)

, ARKK

ARK Innovation ETF

$37.82 /

-0.6 (-1.56%)

, ACB

Aurora Cannabis

/

+

, NVAX

Novavax

$5.77 /

-0.005 (-0.09%)

, GNS

Genius Group

$2.10 /

-0.11 (-4.98%)

, QS

QuantumScape

$7.55 /

+0.05 (+0.67%)

, TLRY

Tilray

$2.60 /

+0.04 (+1.56%)

, IBM

IBM

$123.37 /

-0.65 (-0.52%)

, ARVL

Arrival

/

+

, BITI

Biotie Therapies

$20.76 /

-1.52 (-6.82%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Kimball International (KBAL) 7.85% +2.07, ARK Innovation ETF (ARKK) 4.42% +0.47, Aurora Cannabis (ACB) 11.50% +0.38, Novavax (NVAX) 43.76% +0.24, Genius Group LTD (GNS) 176.08% +0.20, Quantumscape (QS) 21.51% +0.18, Tilray (TLRY) 9.03% +0.18, IBM (IBM) 0.41% +0.16, Arrival (ARVL) 17.79% +0.13, and ProShares Short Bitcoin Strategy ETF (BITI) 13.28% +0.13.

ShowHide Related Items >><<
TLRY Tilray
$2.60 /

+0.04 (+1.56%)

QS QuantumScape
$7.55 /

+0.05 (+0.67%)

NVAX Novavax
$5.77 /

-0.005 (-0.09%)

KBAL Kimball International
$12.23 /

+0.04 (+0.33%)

IBM IBM
$123.37 /

-0.65 (-0.52%)

GNS Genius Group
$2.10 /

-0.11 (-4.98%)

BITI Biotie Therapies
$20.76 /

-1.52 (-6.82%)

ARVL Arrival
/

+

ACB Aurora Cannabis
/

+

KBAL Kimball International
$12.23 /

+0.04 (+0.33%)

11/29/22 Benchmark
Benchmark starts Kimball International at Buy, sees exposure in 'right' markets
11/29/22 Benchmark
Kimball International initiated with a Buy at Benchmark
ARKK ARK Innovation ETF
$37.82 /

-0.6 (-1.56%)

ACB Aurora Cannabis
/

+

02/13/23 CIBC
Aurora Cannabis price target lowered to C$1.75 from C$2.25 at CIBC
02/10/23 Canaccord
Aurora Cannabis price target lowered to C$1.50 from C$2 at Canaccord
02/10/23 Canaccord
Aurora Cannabis price target lowered to C$1.50 from C$2.00 at Canaccord
01/27/23 Stifel
Aurora Cannabis price target lowered to C$1.45 from C$1.75 at Stifel
NVAX Novavax
$5.77 /

-0.005 (-0.09%)

03/01/23 B. Riley
B. Riley downgrades 'show-me story' Novavax amid liquidity challenge
03/01/23 B. Riley
Novavax downgraded to Neutral from Buy at B. Riley
02/17/23 B. Riley
Novavax price target lowered to $29 from $37 at B. Riley
02/13/23 H.C. Wainwright
H.C. Wainwright reiterates Top Pick Buy on Novavax after partnership extension
GNS Genius Group
$2.10 /

-0.11 (-4.98%)

QS QuantumScape
$7.55 /

+0.05 (+0.67%)

01/25/23 Morgan Stanley
QuantumScape price target lowered to $3 from $4 at Morgan Stanley
12/13/22 Goldman Sachs
QuantumScape downgraded to Sell from Neutral at Goldman Sachs
11/09/22 Morgan Stanley
Morgan Stanley cuts QuantumScape to Underweight after 'narrative changing' Q3
11/09/22 Morgan Stanley
QuantumScape downgraded to Underweight from Equal Weight at Morgan Stanley
TLRY Tilray
$2.60 /

+0.04 (+1.56%)

01/10/23 MKM Partners
Tilray price target lowered to $3 from $4 at MKM Partners
01/10/23 Canaccord
Tilray price target lowered to $5 from $7 at Canaccord
01/09/23 Alliance Global Partners
Tilray price target lowered to $3 from $4 at Alliance Global Partners
12/28/22 Piper Sandler
Tilray estimates lowered on softer beer sales at Piper Sandler
IBM IBM
$123.37 /

-0.65 (-0.52%)

02/06/23 Edward Jones
IBM downgraded to Hold from Buy at Edward Jones
01/31/23 Evercore ISI
IBM removed from 'Tactical Outperform' list at Evercore ISI
01/26/23 BMO Capital
IBM price target raised to $155 from $148 at BMO Capital
01/26/23 Morgan Stanley
IBM price target lowered to $143 from $148 at Morgan Stanley
ARVL Arrival
/

+

11/08/22 TD Cowen
Cowen downgrades Arrival Group amid amended production focus
11/08/22 TD Cowen
Arrival Group downgraded to Market Perform from Outperform at Cowen
08/15/22 TD Cowen
Arrival Group price target lowered to $5.50 from $12 at Cowen
BITI Biotie Therapies
$20.76 /

-1.52 (-6.82%)

TLRY Tilray
$2.60 /

+0.04 (+1.56%)

QS QuantumScape
$7.55 /

+0.05 (+0.67%)

NVAX Novavax
$5.77 /

-0.005 (-0.09%)

IBM IBM
$123.37 /

-0.65 (-0.52%)

GNS Genius Group
$2.10 /

-0.11 (-4.98%)

ARVL Arrival
/

+

ACB Aurora Cannabis
/

+

  • 16
    Dec
  • 27
    May
  • 12
    Apr
NVAX Novavax
$5.77 /

-0.005 (-0.09%)

IBM IBM
$123.37 /

-0.65 (-0.52%)

ARVL Arrival
/

+

ACB Aurora Cannabis
/

+

TLRY Tilray
$2.60 /

+0.04 (+1.56%)

QS QuantumScape
$7.55 /

+0.05 (+0.67%)

NVAX Novavax
$5.77 /

-0.005 (-0.09%)

IBM IBM
$123.37 /

-0.65 (-0.52%)

BITI Biotie Therapies
$20.76 /

-1.52 (-6.82%)

ACB Aurora Cannabis
/

+

TLRY Tilray
$2.60 /

+0.04 (+1.56%)

QS QuantumScape
$7.55 /

+0.05 (+0.67%)

NVAX Novavax
$5.77 /

-0.005 (-0.09%)

KBAL Kimball International
$12.23 /

+0.04 (+0.33%)

IBM IBM
$123.37 /

-0.65 (-0.52%)

GNS Genius Group
$2.10 /

-0.11 (-4.98%)

BITI Biotie Therapies
$20.76 /

-1.52 (-6.82%)

ARVL Arrival
/

+

ARKK ARK Innovation ETF
$37.82 /

-0.6 (-1.56%)

ACB Aurora Cannabis
/

+

Thursday
Options
Largest borrow rate increases among liquid names » 08:45
03/23/23
03/23
08:45
03/23/23
08:45
KBAL

Kimball International

$12.18 /

+0.03 (+0.25%)

, NVAX

Novavax

$5.78 /

-0.255 (-4.23%)

, UPST

Upstart

$14.12 /

-1.085 (-7.14%)

, RYAM

Rayonier Advanced Materials

$6.31 /

-0.085 (-1.33%)

, UNP

Union Pacific

$185.72 /

-3.7 (-1.95%)

, KBE

KBW Bank ETF

$36.00 /

-1.98 (-5.21%)

, ASTL

Algoma Steel

$7.60 /

-0.255 (-3.25%)

, BBBY

Bed Bath & Beyond

/

+

, HUT

Hut 8 Mining

$1.76 /

-0.235 (-11.81%)

, MMAT

Meta Materials

/

+

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Kimball International (KBAL) 9.02% +3.50, Novavax (NVAX) 49.86% +0.94, Upstart Holdings (UPST) 46.23% +0.59, Rayonier Advanced Materials (RYAM) 0.94% +0.54, Union Pacific (UNP) 0.70% +0.45, SPDR S&P Bank (KBE) 3.30% +0.40, Algoma Steel (ASTL) 4.28% +0.38, Bed Bath & Beyond (BBBY) 112.86% +0.36, Hut 8 Mining (HUT) 35.32% +0.34, and Meta Materials (MMAT) 13.32% +0.33.

ShowHide Related Items >><<
UPST Upstart
$14.12 /

-1.085 (-7.14%)

UNP Union Pacific
$185.72 /

-3.7 (-1.95%)

RYAM Rayonier Advanced Materials
$6.31 /

-0.085 (-1.33%)

NVAX Novavax
$5.78 /

-0.255 (-4.23%)

MMAT Meta Materials
/

+

KBAL Kimball International
$12.18 /

+0.03 (+0.25%)

HUT Hut 8 Mining
$1.76 /

-0.235 (-11.81%)

BBBY Bed Bath & Beyond
/

+

ASTL Algoma Steel
$7.60 /

-0.255 (-3.25%)

KBAL Kimball International
$12.18 /

+0.03 (+0.25%)

11/29/22 Benchmark
Benchmark starts Kimball International at Buy, sees exposure in 'right' markets
11/29/22 Benchmark
Kimball International initiated with a Buy at Benchmark
NVAX Novavax
$5.78 /

-0.255 (-4.23%)

03/01/23 B. Riley
B. Riley downgrades 'show-me story' Novavax amid liquidity challenge
03/01/23 B. Riley
Novavax downgraded to Neutral from Buy at B. Riley
02/17/23 B. Riley
Novavax price target lowered to $29 from $37 at B. Riley
02/13/23 H.C. Wainwright
H.C. Wainwright reiterates Top Pick Buy on Novavax after partnership extension
UPST Upstart
$14.12 /

-1.085 (-7.14%)

03/07/23 Compass Point
Compass Point starts Upstart with a Sell, $6 price target
03/07/23 Compass Point
Upstart initiated with a Sell at Compass Point
02/21/23 Mizuho
Upstart price target lowered to $14 from $16 at Mizuho
02/15/23 Loop Capital
Loop Capital upgrades Upstart to Buy, expects volume growth to return after Q1
RYAM Rayonier Advanced Materials
$6.31 /

-0.085 (-1.33%)

01/09/23 RBC Capital
Rayonier Advanced Materials cut to Sector Perform at RBC Capital on valuation
01/09/23 RBC Capital
Rayonier Advanced downgraded to Sector Perform from Outperform at RBC Capital
10/13/22 BofA
Rayonier Advanced Materials price target lowered to $1.90 from $2.60 at BofA
07/18/22 RBC Capital
Rayonier Advanced Materials upgraded to Outperform at RBC Capital
UNP Union Pacific
$185.72 /

-3.7 (-1.95%)

03/15/23 Deutsche Bank
Union Pacific price target lowered to $207 from $215 at Deutsche Bank
02/27/23 RBC Capital
Union Pacific upgraded to Sector Perform at RBC amid activism
02/27/23 RBC Capital
Union Pacific upgraded to Sector Perform from Underperform at RBC Capital
02/27/23 Stephens
Activist adds 'another layer of pressure' on Union Pacific, says Stephens
KBE KBW Bank ETF
$36.00 /

-1.98 (-5.21%)

ASTL Algoma Steel
$7.60 /

-0.255 (-3.25%)

03/14/23 BMO Capital
Algoma Steel coverage transferred with an Outperform rating at BMO Capital
02/15/23 BMO Capital
Algoma Steel price target raised to C$15 from C$11 at BMO Capital
01/18/23 Stifel
Algoma Steel upgraded to Buy from Hold at Stifel
01/10/23 BMO Capital
Algoma Steel price target lowered to C$11 from C$14 at BMO Capital
BBBY Bed Bath & Beyond
/

+

02/08/23 Wedbush
Wedbush keeps Underperform on Bed Bath & Beyond, ups price target to 25c
02/08/23 Piper Sandler
Target price target raised to $220 from $200 at Piper Sandler
02/07/23 Odeon Capital
Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital
02/07/23 Wedbush
Wedbush cuts Bed Bath & Beyond target to 0c amid last effort to avoid bankruptcy
HUT Hut 8 Mining
$1.76 /

-0.235 (-11.81%)

03/13/23 Canaccord
Hut 8 Mining price target lowered to $5.00 from $6.00 at Canaccord
12/09/22 H.C. Wainwright
Hut 8 Mining assumed with a Neutral at H.C. Wainwright
11/11/22 Craig-Hallum
Hut 8 Mining downgraded to Hold from Buy at Craig-Hallum
11/11/22 Craig-Hallum
Hut 8 Mining downgraded to Hold from Buy at Craig-Hallum
MMAT Meta Materials
/

+

02/17/23 Alliance Global Partners
Meta Materials initiated with a Buy at Alliance Global Partners
UPST Upstart
$14.12 /

-1.085 (-7.14%)

UNP Union Pacific
$185.72 /

-3.7 (-1.95%)

RYAM Rayonier Advanced Materials
$6.31 /

-0.085 (-1.33%)

NVAX Novavax
$5.78 /

-0.255 (-4.23%)

MMAT Meta Materials
/

+

BBBY Bed Bath & Beyond
/

+

ASTL Algoma Steel
$7.60 /

-0.255 (-3.25%)

  • 16
    Dec
UNP Union Pacific
$185.72 /

-3.7 (-1.95%)

NVAX Novavax
$5.78 /

-0.255 (-4.23%)

BBBY Bed Bath & Beyond
/

+

UPST Upstart
$14.12 /

-1.085 (-7.14%)

UNP Union Pacific
$185.72 /

-3.7 (-1.95%)

RYAM Rayonier Advanced Materials
$6.31 /

-0.085 (-1.33%)

NVAX Novavax
$5.78 /

-0.255 (-4.23%)

MMAT Meta Materials
/

+

HUT Hut 8 Mining
$1.76 /

-0.235 (-11.81%)

BBBY Bed Bath & Beyond
/

+

ASTL Algoma Steel
$7.60 /

-0.255 (-3.25%)

UPST Upstart
$14.12 /

-1.085 (-7.14%)

UNP Union Pacific
$185.72 /

-3.7 (-1.95%)

RYAM Rayonier Advanced Materials
$6.31 /

-0.085 (-1.33%)

NVAX Novavax
$5.78 /

-0.255 (-4.23%)

MMAT Meta Materials
/

+

KBE KBW Bank ETF
$36.00 /

-1.98 (-5.21%)

HUT Hut 8 Mining
$1.76 /

-0.235 (-11.81%)

BBBY Bed Bath & Beyond
/

+

Over a week ago
Hot Stocks
HNI Corporation to acquire Kimball International for $485M in cash and stock » 06:53
03/08/23
03/08
06:53
03/08/23
06:53
HNI

HNI Corporation

$29.95 /

-0.09 (-0.30%)

, KBAL

Kimball International

$6.70 /

-0.035 (-0.52%)

HNI Corporation (HNI) and…

HNI Corporation (HNI) and Kimball International (KBAL) announced that they have entered into a definitive agreement under which HNI will acquire all the outstanding shares of Kimball International in a cash and stock transaction valued at approximately $485M. Under the terms of the agreement, Kimball International shareholders will receive $9.00 in cash and 0.1301 shares of HNI common stock for each share of Kimball International common stock they own. As a result of the transaction, Kimball International shareholders will own approximately 10% of the combined company. Following the close of the transaction, the combined company will continue to be led by Jeff Lorenger, HNI's Chairman, President, and Chief Executive Officer. Juster will remain in her current role with Kimball International until the closing to ensure a seamless transition. The combined company will have pro forma annual revenue of approximately $3.1 billion and pro forma adjusted EBITDA of approximately $290 million, inclusive of annual run-rate synergies, based on each company's respective last reported 12 months. The combination is expected to generate $25 million of annual run-rate cost synergies within three years of closing. Based on HNI's closing share price as of March 7, 2023, the last day prior to today's announcement, the total implied per share consideration equals $12.90, representing a premium on Kimball International's 30-day VWAP of 81%. The consideration implies a valuation multiple of approximately 6.8x calendar year 2022 adjusted EBITDA, inclusive of synergies. The transaction has been unanimously approved by the Boards of Directors of both companies and is expected to close by mid-2023, subject to the approval of Kimball International shareholders, the receipt of required regulatory approval, and the satisfaction of other customary closing conditions.

ShowHide Related Items >><<
HNI HNI Corporation
$29.95 /

-0.09 (-0.30%)

HNI HNI Corporation
$29.95 /

-0.09 (-0.30%)

08/01/22 Sidoti
HNI Corporation downgraded to Neutral from Buy at Sidoti
KBAL Kimball International
$6.70 /

-0.035 (-0.52%)

11/29/22 Benchmark
Benchmark starts Kimball International at Buy, sees exposure in 'right' markets
11/29/22 Benchmark
Kimball International initiated with a Buy at Benchmark
HNI HNI Corporation
$29.95 /

-0.09 (-0.30%)

HNI HNI Corporation
$29.95 /

-0.09 (-0.30%)

Over a quarter ago
Conference/Events
Kimball International management to meet virtually with Benchmark » 12:32
12/19/22
12/19
12:32
12/19/22
12:32
KBAL

Kimball International

$6.25 /

-0.08 (-1.26%)

Virtual Meeting to be…

Virtual Meeting to be held with CEO Juster and CFO Wolfe on December 19 hosted by Benchmark.

ShowHide Related Items >><<
KBAL Kimball International
$6.25 /

-0.08 (-1.26%)

11/29/22 Benchmark
Benchmark starts Kimball International at Buy, sees exposure in 'right' markets
11/29/22 Benchmark
Kimball International initiated with a Buy at Benchmark
Conference/Events
Kimball International management to meet virtually with Benchmark » 04:55
12/12/22
12/12
04:55
12/12/22
04:55
KBAL

Kimball International

$6.30 /

-0.18 (-2.78%)

Virtual Meeting to be…

Virtual Meeting to be held with CEO Juster and CFO Wolfe on December 12 at 11 am hosted by Benchmark.

ShowHide Related Items >><<
KBAL Kimball International
$6.30 /

-0.18 (-2.78%)

11/29/22 Benchmark
Benchmark starts Kimball International at Buy, sees exposure in 'right' markets
11/29/22 Benchmark
Kimball International initiated with a Buy at Benchmark
Conference/Events
Kimball International management to meet virtually with Benchmark » 13:39
12/09/22
12/09
13:39
12/09/22
13:39
KBAL

Kimball International

$6.45 /

-0.03 (-0.46%)

Virtual Meeting to be…

Virtual Meeting to be held with CEO Juster and CFO Wolfe on December 12 at 11 am hosted by Benchmark.

ShowHide Related Items >><<
KBAL Kimball International
$6.45 /

-0.03 (-0.46%)

11/29/22 Benchmark
Benchmark starts Kimball International at Buy, sees exposure in 'right' markets
11/29/22 Benchmark
Kimball International initiated with a Buy at Benchmark
Initiation
Benchmark starts Kimball International at Buy, sees exposure in 'right' markets » 16:19
11/29/22
11/29
16:19
11/29/22
16:19
KBAL

Kimball International

$7.05 /

-0.17 (-2.35%)

As previously reported,…

As previously reported, Benchmark analyst Reuben Garner initiated coverage of Kimball International with a Buy rating and $12 price target. While the commercial furnishings business faces a challenging broader macro environment, Kimball is positioned with exposure to "the right portions of the market" in terms of product type, geographic mix and end markets, Garner tells investors. Kimball, which has emerged from the pandemic a "more effective and soon-to-be profitable organization," remains underfollowed, the analyst added.

ShowHide Related Items >><<
KBAL Kimball International
$7.05 /

-0.17 (-2.35%)

11/29/22 Benchmark
Kimball International initiated with a Buy at Benchmark
Initiation
Kimball International initiated with a Buy at Benchmark » 16:15
11/29/22
11/29
16:15
11/29/22
16:15
KBAL

Kimball International

$7.05 /

-0.17 (-2.35%)

Benchmark analyst Reuben…

Benchmark analyst Reuben Garner initiated coverage of Kimball International with a Buy rating and $12 price target.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.